GU Cancers 2023 | Using radiotherapy to manage oligometastatic kidney cancer

Shankar Siva, PhD, Peter MacCallum Cancer Centre, Melbourne, Australia, explains how radiotherapy can be used in the management of oligometastatic kidney cancer. Strategies include using stereotactic body radiotherapy (SBRT) to delay the start of systemic therapy, as well as combining SBRT with immunotherapy. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.